Abstract: A monitoring system comprises a monitoring device, a terminal device that has an imaging function and transmits identification information, and the monitoring center. The monitoring device performs an authentication process of the terminal device based on the identification information received, and transmits first information that associates an authentication time, region information for specifying a monitoring region, and the identification information received. The terminal device transmits second information that associates an image in the monitoring region captured, a capture time of the image, and the identification information.

Abstract: Provided is a therapeutic or prophylactic agent for pain or interstitial cystitis comprising N-[2-(6,6-dimethyl-4,5,6,7-tetrahydro-H-indazol-3-yl)-1H-indol-6-yl]-N-methyl-(2S)-2-(morpholin-4-yl)propanamide or a pharmaceutically acceptable salt thereof.

Abstract: Provided is a therapeutic or prophylactic agent for pain or interstitial cystitis comprising N-[2-(6,6-dimethyl-4,5,6,7-tetrahydro-H-indazol-3-yl)-1H-indol-6-yl]-N-methyl-(2S)-2-(morpholin-4-yl)propanamide or a pharmaceutically acceptable salt thereof.

Abstract: In an address translation buffer, multiple content-addressable memories of a first memory array store previous process identifiers for comparing them with a new process identifier to produce a first output signal when a coincidence is detected and a second output signal when a coincidence is not detected. Multiple drivers are associated respectively with the memories of the first memory array. Power saving of the drivers is achieved by having each driver pull up its output line as an indication of a match only when the first output signal of the associated memory coincides with a precharge signal and pull down its output line in response to a discharge signal when the associated memory subsequently produces the second output signal. Multiple content-addressable memories of a second memory array correspond respectively to the drivers.